Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

PharmAnalysis Group

M&A STATUS
11-20 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of reimbursement planning for the pharmaceutical, biotechnology, medical device and diagnostics industries. The company's services include reimbursement and economic assessments, qualitative pricing and reimbursement research, coding analysis, marketing support, communications, and program development. It serves pharmaceutical, biotechnology, medical device, and diagnostics industries.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Consulting Services (B2B)
Acquirer
Primary Office
  • 2700 South Quincy Street
  • Suite 230
  • Arlington, VA 22206
  • United States

+1 (703) 000-0000

PharmAnalysis Group Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore PharmAnalysis Group‘s full profile, request access.

Request full access to PitchBook

PharmAnalysis Group Executive Team (4)

Name Title Board
Seat
Contact
Info
Diane Simison Ph.D Executive Director
Laurie Hughes Executive Director
Sandy Robinson Vice President
Nancy Leidy President & CEO